TVGN
Tevogen Bio Holdings Inc.
7.80$
+5.1%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +7.8% | -2.5% | -117.5% | – | -52.7% | +1.8% | -74.8% | +995.9% | -161.2% | – | +1.9% | – | |
| – | – | – | -84.3% | -19.7% | +109.2% | +4.8% | -55.6% | +0.2% | -24.6% | +16.5% | +15.4% | – | |
| – | -115.8% | – | +165.4% | -183.6% | – | – | – | – | – | – | – | – | |
| – | +0.0% | +150.0% | -100.0% | – | -100.0% | – | +0.0% | +33.3% | +1,610,725.0% | -100.0% | +200.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -97.1% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -100.0% | – | -30.0% | -100.0% | – | – | -100.0% | – | |
| – | -55.6% | +475.3% | +15.3% | +78.6% | -60.0% | +100.0% | -52.5% | +110.6% | -56.0% | +63.2% | +18.1% | – | |
| – | – | -62.3% | -168.7% | – | -187.7% | – | -286.4% | – | -237.8% | – | +178.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.